Literature DB >> 7520084

Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.

M E Churchill1, E A Stura, C Pinilla, J R Appel, R A Houghten, D H Kono, R S Balderas, G G Fieser, U Schulze-Gahmen, I A Wilson.   

Abstract

The three-dimensional structure of the complex of a second anti-peptide antibody (Fab 26/9) that recognizes the same six-residue epitope of an immunogenic peptide from influenza virus hemagglutinin (HA1; 75-110) as Fab 17/9 with the peptide has been determined at 2.8 A resolution. The amino acid sequence of the variable region of the 26/9 antibody differs in 24 positions from that of 17/9, the first antibody in this series for which several ligand-bound and free structures have been determined and refined. Comparison of the 26/9-peptide with the 17/9-peptide complex structures shows that the two Fabs are very similar (r.m.s.d. 0.5 to 0.8 A) and that the peptide antigen (101-107) has virtually the same conformation (r.m.s.d. 0.3 to 0.8 A) when bound to both antibodies. A sequence difference in the 26/9 binding pocket (L94; His in 26/9, Asn in 17/9) results in an interaction with a bound water molecule that is not seen in the 17/9 structures. Epitope mapping shows that the relative specificity of 26/9 and 17/9 antibodies for individual positions of the peptide antigen are slightly different. Amino acid substitutions in the peptide, particularly at position SerP107, are tolerated to different extents by 17/9 and 26/9. Structural and sequence analysis suggests that amino acid differences near the peptide-binding site are responsible for altering slightly the specificity of 26/9 for three peptide residues and illustrates how amino acid substitutions can modify antibody-antigen interactions and thereby modulate antibody specificity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520084     DOI: 10.1006/jmbi.1994.1530

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  Identification of protein functions from a molecular surface database, eF-site.

Authors:  Kengo Kinoshita; Jun'ichi Furui; Haruki Nakamura
Journal:  J Struct Funct Genomics       Date:  2002

2.  Exploring antibody polyspecificity using synthetic combinatorial libraries.

Authors:  J R Appel; J Buencamino; R A Houghten; C Pinilla
Journal:  Mol Divers       Date:  1996-10       Impact factor: 2.943

3.  Xenoprotein engineering via synthetic libraries.

Authors:  Zachary P Gates; Alexander A Vinogradov; Anthony J Quartararo; Anupam Bandyopadhyay; Zi-Ning Choo; Ethan D Evans; Kathryn H Halloran; Alexander J Mijalis; Surin K Mong; Mark D Simon; Eric A Standley; Evan D Styduhar; Sarah Z Tasker; Faycal Touti; Jessica M Weber; Jessica L Wilson; Timothy F Jamison; Bradley L Pentelute
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-21       Impact factor: 11.205

4.  Identification of the epitopes of calcitonin gene-related peptide (CGRP) for two anti-CGRP monoclonal antibodies by 2D NMR.

Authors:  J A Hubbard; D P Raleigh; J R Bonnerjea; C M Dobson
Journal:  Protein Sci       Date:  1997-09       Impact factor: 6.725

5.  Topography and immunogenicity of bluetongue virus VP7 epitopes.

Authors:  L F Wang; A D Hyatt; P L Whiteley; M Andrew; J K Li; B T Eaton
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Ribosome display of combinatorial antibody libraries derived from mice immunized with heat-killed Xylella fastidiosa and the selection of MopB-specific single-chain antibodies.

Authors:  Armaghan Azizi; Arinder Arora; Anatoliy Markiv; David J Lampe; Thomas A Miller; Angray S Kang
Journal:  Appl Environ Microbiol       Date:  2012-02-10       Impact factor: 4.792

7.  Antibody quantity versus quality after influenza vaccination.

Authors:  JingQi Feng; Upma Gulati; Xiaoju Zhang; Wendy A Keitel; David M Thompson; Judith A James; Linda F Thompson; Gillian M Air
Journal:  Vaccine       Date:  2009-10-23       Impact factor: 3.641

8.  The human immunodeficiency virus type 1 envelope spike of primary viruses can suppress antibody access to variable regions.

Authors:  Ralph Pantophlet; Meng Wang; Rowena O Aguilar-Sino; Dennis R Burton
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

9.  Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo.

Authors:  Joshua A Horwitz; Yotam Bar-On; Ching-Lan Lu; Daniela Fera; Ainsley A K Lockhart; Julio C C Lorenzi; Lilian Nogueira; Jovana Golijanin; Johannes F Scheid; Michael S Seaman; Anna Gazumyan; Susan Zolla-Pazner; Michel C Nussenzweig
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

10.  In vitro affinity screening of protein and peptide binders by megavalent bead surface display.

Authors:  Letizia Diamante; Pietro Gatti-Lafranconi; Yolanda Schaerli; Florian Hollfelder
Journal:  Protein Eng Des Sel       Date:  2013-08-26       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.